ArticleGut2021
Utility of minimally invasive measurement of hepatic venous pressure gradient via the peripheral antecubital vein.
Article in Gut, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 13 citations in OpenAlex.
- Characteristics and treatment outcomes of portal hypertension after living donor liver transplantation.Surgery today · 2026Article
- Deep-learning-based prediction of significant portal hypertension with single cross-sectional non-enhanced CT.European radiology · 2026Article
- Advances in portal pressure measurement: Endoscopic techniques, challenges, and implications for liver transplantation.World journal of hepatology · 2025Review
- Transjugular diagnostic procedures in hepatology: Indications, techniques and interpretation.JHEP reports : innovation in hepatology · 2025Review
- Standard technique in Japan for measuring hepatic venous pressure gradient.Journal of gastroenterology · 2025Review
- [HVPG minimally invasive era: exploration based on forearm venous approach].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2024Article
- Recent Advances in the Pathogenesis and Clinical Evaluation of Portal Hypertension in Chronic Liver Disease.Gut and liver · 2024Review
- Ibrutinib Induces a Dramatic Improvement for Idiopathic Refractory Ascites Following Allogeneic Hematopoietic Cell Transplantation.Internal medicine (Tokyo, Japan) · 2023Article
- Antecubital vein approach of retrograde transvenous obliteration using a steerable triaxial system for portosystemic encephalopathy.Radiology case reports · 2023Article
- Short-term hepatocyte function and portal hypertension outcomes of sofosbuvir/velpatasvir for decompensated hepatitis C-related cirrhosis.Journal of gastroenterology · 2023Article
- [Status of HVPG clinical application in China in 2021].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2022Article
- Number of endoscopic sessions to eradicate varices identifies high risk of rebleeding in cirrhotic patients.BMC gastroenterology · 2022Article
- Splenic non-infarction volume determines a clinically significant hepatic venous pressure gradient response to partial splenic embolization in patients with cirrhosis and hypersplenism.Journal of gastroenterology · 2021Article
Corrections and comments
- Comment on
- Comment on
- Comment on
Authors and funding
12 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.